Market Value237,227,000
Total Holdings54
File Date2022-08-12
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NVAX / Novavax, Inc. Put
NVAX / Novavax, Inc. Call
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock) Call
COGT / Cogent Biosciences, Inc.
ATHX / Athersys, Inc. Put
NSTG / NanoString Technologies, Inc.
RCOR.WS / Renovacor, Inc. Warrants, enti Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11.50 per whole share
CHAQ / Chardan Healthcare Acquisition 2 Corp
LSAQ / LifeSci Acquisition II Corp
KDNY / Chinook Therapeutics Inc
MRNA / Moderna, Inc. Call
GBT / Global Blood Therapeutics Inc.
KYG5960S1241 / Medicus Sciences Acquisition Corp.
CELU / Celularity Inc. Put
US63009RAD17 / NanoString Technologies Inc
BEAM / Beam Therapeutics Inc. Call
CALA / Calithera Biosciences, Inc.
US761299AB20 / Retrophin Inc Bond
US10806XAB82 / Bridgebio Pharma, Inc.
/ Nautilus Biotechnology Inc
US10806XAD49 / BRIDGEBIO PHARMA INC
MSAC / Medicus Sciences Acquisition Corp - Class A
HSAQ / Health Sciences Acquisitions Corp 2
HYPR / Hyperfine, Inc.
CYCC / Cyclacel Pharmaceuticals, Inc.
PMVP / PMV Pharmaceuticals, Inc. Call
LLY / Eli Lilly and Company Call
RCKT / Rocket Pharmaceuticals, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
BPMC / Blueprint Medicines Corporation
KURA / Kura Oncology, Inc.
PNT / POINT Biopharma Global Inc.
CRIS / Curis, Inc.
ENOB / Enochian Biosciences Inc Put
SPRY / ARS Pharmaceuticals, Inc.
AUPH / Aurinia Pharmaceuticals Inc. Call
KRTX / Karuna Therapeutics, Inc. Put
ARYE / ARYA Sciences Acquisition Corp V - Class A
IOVA / Iovance Biotherapeutics, Inc. Call
FATE / Fate Therapeutics, Inc. Call
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
LIAN / LianBio - Depositary Receipt (Common Stock)
RPTX / Repare Therapeutics Inc.
PTGX / Protagonist Therapeutics, Inc.
ACLX / Arcellx, Inc.
CRSP / CRISPR Therapeutics AG Call
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
ACRS / Aclaris Therapeutics, Inc.
HZNP / Horizon Therapeutics Plc
KRTX / Karuna Therapeutics, Inc.
BLU / Bellus Health Inc
SPY / SPDR S&P 500 ETF Put
VINC / Vincerx Pharma, Inc.
IMTXW / Immatics N.V. - Equity Warrant
CLDX / Celldex Therapeutics, Inc.
CERE / Cerevel Therapeutics Holdings, Inc.
CLDX / Celldex Therapeutics, Inc. Call
MDGL / Madrigal Pharmaceuticals, Inc.
CNTX / Context Therapeutics Inc.
VRDN / Viridian Therapeutics, Inc.
TVTX / Travere Therapeutics, Inc.
SWTX / SpringWorks Therapeutics, Inc.
SWTX / SpringWorks Therapeutics, Inc. Put
CBAY / CymaBay Therapeutics, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
RLAY / Relay Therapeutics, Inc. Call
LNTH / Lantheus Holdings, Inc.
LNTH / Lantheus Holdings, Inc. Put
CYTK / Cytokinetics, Incorporated
PTGX / Protagonist Therapeutics, Inc. Put
ESTA / Establishment Labs Holdings Inc.
ESTA / Establishment Labs Holdings Inc. Put
MORF / Morphic Holding, Inc.
TERN / Terns Pharmaceuticals, Inc.
NARI / Inari Medical, Inc.
XENE / Xenon Pharmaceuticals Inc.